Shares of Illumina (ILMN) are on the rise on Tuesday after the company announced during the JPMorgan Healthcare conference a 2022 revenue outlook that beat analysts’ estimates on strong demand for its gene sequencing business. The company also… To see the rest of the story go to thefly.com. (See Story Here):(https://www.thefly.com/permalinks/entry.php/id3438875/-Illumina-jumps-as-gene-sequencing-demand-drives-stronger-outlook)
previous post
next post